Oncology Platform

NeoGenomics Acquires Precision Oncology Platform Trapelo Health for $65M

What You Should Know: – NeoGenomics, Inc., a provider of cancer-focused genetic testing services and global oncology contract research services announced it has reached an agreement to acquire precision oncology platform Trapelo Health for $65M. The agreement purchase price of $65 million, consists of $35 million in cash on hand and $30 million in NeoGenomics …

NeoGenomics Acquires Precision Oncology Platform Trapelo Health for $65M Read More »

Syapse Lands $68M to Expand Global Precision Oncology Data Sharing Network

What You Should Know: – Syapse raises 68M in equity investment  led by Ally Bridge Group (ABG), with Northpond Ventures to expand delivery of real-world evidence  through Syapse’s Learning Health Network. – The Syapse Learning Health Network is a global precision oncology data sharing network, improving cancer care across communities by using real-world data to …

Syapse Lands $68M to Expand Global Precision Oncology Data Sharing Network Read More »

COTA Lands $34M to Drive Innovation in Oncology Using Real-World Data

What You Should Know: – COTA, Inc., a healthcare technology company that uses real-world data to bring clarity to cancer care, has secured $34M in funding. – Access to over one million patient data records and additional funding support enhanced real-world data and analytics services in oncology. COTA, Inc., a Boston, MA-based healthcare technology company …

COTA Lands $34M to Drive Innovation in Oncology Using Real-World Data Read More »

M&A: RxVantage Acquires onPoint Oncology to Expand Offering to Oncology Practices

What You Should Know: – RxVantage has acquired onPoint Oncology to provide cancer care teams with on-demand access to educational resources, reimbursement data, and analytics. – The acquisition of onPoint Oncology builds on RxVantage’s rapidly expanding digital offerings for providers. In April, RxVantage launched Virtual Meetings to help providers reestablish access to life science experts amidst the disruptions caused …

M&A: RxVantage Acquires onPoint Oncology to Expand Offering to Oncology Practices Read More »

CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform

What You Should Know: – CancerIQ raises $5M in Series A funding led by HealthXVentures to accelerate the growth of its genetic cancer risk assessment platform to identify and manage patients at high risk of cancer. – CancerIQ’s technology enables hospitals to use genomics to personalize the prevention and early detection of cancer. – Two …

CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform Read More »